'Monopoly Prices'?: Big Pharma Co. Amgen Accused of Anticompetitive Conduct
“A 50-mg dose of Enbrel now costs patients $7,401.83 per month: 643% more than it cost when launched in 1998,” according to the allegations in the antitrust class action filed against Enbrel manufacturer Amgen Inc.
CEO of Speaker Media and Marketing, is the "Secret Weapon of Personal Injury Lawyers and Trial Attorneys" throughout the United States. Specializing as a marketing consultant to lawyers, with a primary focus on content marketing, social media, online video and mobile marketing strategies.
Click Here To Read The Full Article
Navigation 